← State exam

76. Chronic pancreatitis, pancreatic cysts and fistulas

High yield

Progressive fibrosis causing pain and gland failure; pseudocysts, cystic neoplasms and fistulas each need their own plan.

Exam Prep · State examSurgery · HPB

1. Definition

  • Chronic pancreatitis → progressive inflammation and fibrosis of the pancreas with permanent loss of exocrine and endocrine function, and pain
  • Pancreatic cysts:
    • Pseudocyst → collection of pancreatic fluid with a fibrous wall without epithelium, more than 4 weeks after pancreatitis
    • Cystic neoplasms → cysts lined by epithelium: serous cystadenoma, mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN), solid pseudopapillary neoplasm (SPN)
    • True congenital cysts, retention cysts (rare)
  • Pancreatic fistula → abnormal communication between the pancreatic duct and another surface:
    • External → to the skin (after surgery, drains, trauma)
    • Internal → to the peritoneum (pancreatic ascites), pleura (pancreatic pleural effusion), or bowel

2. Epidemiology

  • Chronic pancreatitis → about 5–12 per 100,000 a year; men, age 40–50
  • Alcohol → cause in about 50–70% in the West; smoking an independent and additive risk
  • Pseudocysts → 10–20% of acute and 20–40% of chronic pancreatitis
  • Pancreatic cystic lesions → found on 2–3% of CT and up to 20–45% of MRI scans (incidental, more with age)
  • IPMN → most common cystic neoplasm (resected), older men and women
  • MCN → almost always women (over 95%), body and tail, 40–60 years
  • Serous cystadenoma → older women ("grandmother"), benign
  • SPN → young women ("daughter"), low-grade malignant
  • Postoperative pancreatic fistula → 10–30% after pancreaticoduodenectomy and distal pancreatectomy

3. Aetiology and risk factors

Chronic pancreatitis (TIGAR-O)

  • Toxic-metabolic → alcohol, smoking, hypercalcaemia, hypertriglyceridaemia, chronic kidney disease
  • Idiopathic → early or late onset, tropical pancreatitis (India, Africa)
  • Genetic → PRSS1 (hereditary pancreatitis), SPINK1, CFTR (cystic fibrosis), CTRC
  • Autoimmune → IgG4-related (type 1) and type 2 autoimmune pancreatitis
  • Recurrent and severe acute pancreatitis
  • Obstructive → pancreas divisum (debated), duct stricture after trauma or necrosis, tumours (IPMN, cancer), sphincter of Oddi stenosis

Pseudocyst

  • Acute pancreatitis (interstitial), chronic pancreatitis, trauma, duct obstruction

Fistula

  • After pancreatic surgery (soft gland, small duct)
  • Drainage of necrosis or pseudocyst
  • Trauma, duct disruption in pancreatitis

4. Pathogenesis

Chronic pancreatitis

  1. Repeated injury (alcohol, smoking) → acinar damage, protein plugs in ducts
  2. Plugs calcify → duct stones, strictures, duct dilatation ("chain of lakes")
  3. Pancreatic stellate cells activated → fibrosis
  4. Loss of acinar tissue → exocrine insufficiency (when over 90% is lost) → steatorrhoea
  5. Loss of islets → diabetes (type 3c; brittle, both insulin and glucagon lost)
  6. Pain → raised duct and tissue pressure, perineural inflammation, central sensitisation
  7. Inflammatory mass in the head (groove pancreatitis or head mass) → compresses the CBD, duodenum, portal and splenic veins

Pseudocyst

  • Duct disruption → leak of pancreatic juice → walled off by granulation tissue and fibrosis over 4 weeks
  • Many resolve when the duct heals; persist if the duct stays disrupted or blocked

Cystic neoplasms

  • IPMN → mucin-producing papillary growth in the ducts; main duct type has high cancer risk (about 60%); branch duct type lower (about 20–25%)
  • MCN → ovarian-type stroma; cancer risk 10–15%
  • Serous cystadenoma → glycogen-rich cells, VHL-associated; almost never malignant

Fistula

  • Disrupted duct + downstream obstruction → juice follows the path of least resistance
  • Disconnected pancreatic duct syndrome → viable tail cut off from the head after necrosis → recurrent collections and fistulas

5. Classification

Chronic pancreatitis

  • By cause → TIGAR-O
  • By duct (Cambridge classification on imaging) → normal, equivocal, mild, moderate, marked (large cavities, stones, strictures, dilated duct)
  • Large-duct (dilated over 7 mm; drainage operations help) or small-duct disease
  • Calcifying, obstructive, autoimmune

Pseudocysts (D'Egidio)

  • Type I → after acute pancreatitis, normal duct
  • Type II → acute on chronic, abnormal duct, no stricture
  • Type III → chronic pancreatitis with duct stricture (needs duct treatment)

Pancreatic cystic neoplasms

  • IPMN → main duct, branch duct, mixed
  • MCN, serous cystadenoma, SPN, cystic neuroendocrine tumour

Postoperative pancreatic fistula (ISGPS 2016)

  • Definition → drain amylase over 3 times the serum upper limit on or after day 3, with a clinical effect
  • Biochemical leak → no clinical effect (no longer called a fistula)
  • Grade B → changes management: drain over 3 weeks, new drains, antibiotics, angioembolisation
  • Grade C → reoperation, organ failure or death
Table comparing pancreatic cysts
Diagram: pseudocyst and cystic neoplasms compared

6. Clinical picture

Symptoms

  • Chronic pancreatitis:
    • Pain (80–90%) → epigastric, radiating to the back, worse after food and alcohol; relieved by sitting forward; constant or in attacks
    • Weight loss (fear of eating, malabsorption)
    • Steatorrhoea → pale, bulky, oily, foul, floating stools
    • Diabetes → thirst, polyuria
    • Opioid dependence
    • "Burnt-out" pancreas → pain may lessen as the gland fails
  • Pseudocyst → persistent pain, early satiety, nausea and vomiting (gastric compression), epigastric mass, jaundice
  • Cystic neoplasms → mostly incidental; pain, pancreatitis (IPMN), jaundice, weight loss and new diabetes suggest malignancy
  • Fistula → clear watery, high-amylase drain fluid; skin excoriation; pancreatic ascites (painless swelling); breathlessness from a pleural effusion

Signs

  • Thin, malnourished; erythema ab igne (from hot water bottles)
  • Epigastric tenderness or mass (pseudocyst, inflammatory mass)
  • Jaundice (CBD stricture)
  • Ascites, pleural effusion (internal fistula)
  • Splenomegaly, gastric varices (splenic vein thrombosis)

7. Diagnosis

Chronic pancreatitis

  • Amylase and lipase → often normal
  • Faecal elastase-1 → low (under 200 µg/g; severe under 100) → exocrine insufficiency
  • HbA1c, glucose
  • LFT (biliary stricture), fat-soluble vitamins (A, D, E, K), magnesium, bone density (osteoporosis)
  • IgG4, calcium, triglycerides; genetic tests in young patients
  • CT → calcification, duct dilatation, atrophy, pseudocysts, mass, vascular complications; first imaging test
  • MRCP (secretin) → duct changes, strictures, "chain of lakes", side branch dilatation
  • EUS → early disease (Rosemont criteria), biopsy of a mass
  • Plain X-ray → pancreatic calcification (in 30%)
  • Exclude cancer in any mass or stricture → CT, EUS-FNA, CA 19-9

Cysts

  • CT or MRI with MRCP → size, wall, septa, communication with the duct, solid parts, duct dilatation
  • EUS with FNA of cyst fluid:
    • CEA over 192 ng/mL → mucinous (IPMN, MCN)
    • Glucose low (under 50 mg/dL) → mucinous
    • Amylase high → pseudocyst or IPMN (duct communication)
    • Cytology, DNA (KRAS, GNAS for IPMN; VHL for serous)
  • Worrying features and high-risk stigmata (Fukuoka 2017, European 2018):
    • High-risk → obstructive jaundice with a cyst in the head, enhancing solid component ≥ 5 mm, main duct ≥ 10 mm, positive cytology
    • Worrying → cyst ≥ 3 cm, thick enhancing wall, main duct 5–9 mm, enhancing mural nodule < 5 mm, duct calibre change with distal atrophy, lymph nodes, raised CA 19-9, growth ≥ 5 mm in 2 years, pancreatitis

Fistula

  • Drain fluid amylase
  • CT → collections; MRCP or ERCP → site of duct leak, disconnected duct, downstream stricture
  • Ascitic or pleural fluid → amylase very high (often over 1,000 IU/L), protein over 30 g/L

8. Differential diagnosis

  • Pancreatic cancer (mass-forming chronic pancreatitis looks the same; check CA 19-9, EUS biopsy)
  • Peptic ulcer disease, biliary colic, mesenteric ischaemia
  • Other malabsorption → coeliac disease, small bowel bacterial overgrowth
  • Cysts → pseudocyst versus cystic neoplasm (no history of pancreatitis, septa, solid parts, duct communication suggest a neoplasm)
  • Ascites of other causes (cirrhosis, malignancy)

9. Treatment

Conservative: chronic pancreatitis

  • Stop alcohol and smoking (slows progression, helps pain)
  • Pain → stepwise analgesia (paracetamol, NSAIDs, weak opioids; avoid strong opioids long term); pregabalin, tricyclics; pain clinic
  • Exocrine insufficiency → pancreatic enzyme replacement (Creon) with meals, 25,000–50,000 lipase units with each meal; PPI if response is poor
  • Diet → normal fat, small frequent meals; fat-soluble vitamins, calcium, vitamin D
  • Diabetes → metformin, insulin (care with hypoglycaemia)
  • Coeliac plexus block (EUS-guided) → short-term pain relief
  • Endoscopic therapy:
    • ERCP with stone extraction and duct stent for strictures
    • ESWL (extracorporeal shock wave lithotripsy) for large duct stones in the head
    • Biliary stent for CBD stricture (temporary; surgery often better long term)
  • Autoimmune pancreatitis → steroids
  • Surveillance → higher pancreatic cancer risk (especially hereditary pancreatitis)

Conservative: cysts and fistulas

  • Pseudocyst → watch if asymptomatic, regardless of size; many resolve
  • Cystic neoplasms:
    • Serous cystadenoma → follow up or leave; resect only if symptomatic or large and growing
    • Branch duct IPMN without worrying features → surveillance by MRI (6 months, then yearly depending on size); stop when unfit for surgery
  • Fistula:
    • Controlled external drainage; protect the skin (stoma bags)
    • Nutrition → enteral preferred (nasojejunal), parenteral if needed
    • Octreotide → may reduce output; no clear effect on closure
    • Most low-output fistulas close in weeks if there is no downstream obstruction
    • ERCP with sphincterotomy and stent across the leak or stricture
    • Pancreatic ascites or pleural effusion → paracentesis or chest drain, nil by mouth, octreotide, ERCP stent

Surgical: chronic pancreatitis

  • Indications → intractable pain, suspicion of cancer, complications (CBD or duodenal obstruction, pseudocyst, bleeding)
  • Earlier surgery gives better pain relief than prolonged endoscopy (ESCAPE trial)
  • Drainage operation (dilated duct over 7 mm, no head mass):
    • Lateral pancreaticojejunostomy (Partington-Rochelle modification of the Puestow procedure) → open the duct along its length, side-to-side Roux-en-Y pancreaticojejunostomy
  • Resection (inflammatory head mass):
    • Frey procedure → local coring of the head + lateral pancreaticojejunostomy
    • Beger procedure → duodenum-preserving pancreatic head resection
    • Berne modification → simpler head excavation
    • Pancreaticoduodenectomy (Whipple) → if cancer is suspected
    • Distal pancreatectomy → disease confined to the tail
  • Total pancreatectomy with islet autotransplantation → diffuse small-duct disease, hereditary pancreatitis, failed other operations
  • Thoracoscopic splanchnicectomy → pain relief in selected patients
  • Biliary bypass (hepaticojejunostomy) for CBD stricture; gastrojejunostomy for duodenal obstruction

Surgical: cysts and fistulas

  • Pseudocyst drainage → when symptomatic, infected, growing, bleeding or obstructing; wait at least 4–6 weeks for a mature wall:
    • Endoscopic cystgastrostomy (EUS-guided, lumen-apposing metal stent) → first choice
    • Endoscopic transpapillary stent if the cyst communicates with the duct
    • Surgical internal drainage (laparoscopic or open) → cystgastrostomy (cyst behind the stomach), cystojejunostomy (Roux-en-Y), cystoduodenostomy
    • Percutaneous drainage → infected cyst in an unfit patient (risk of external fistula)
    • Biopsy the cyst wall at surgery to exclude a cystic neoplasm
    • Never drain a cystic neoplasm as a pseudocyst
    • Bleeding pseudoaneurysm → angioembolisation first
  • Cystic neoplasms:
    • MCN → resect (distal pancreatectomy, often laparoscopic) if over 4 cm or with worrying features; small ones may be watched
    • Main duct IPMN (duct ≥ 10 mm) and high-risk stigmata → resection (Whipple, distal or total pancreatectomy); oncological resection with lymphadenectomy
    • Branch duct IPMN with worrying features → EUS; resect in fit patients
    • SPN → resect (curative in most)
  • Fistula → surgery for failed conservative care, disconnected duct with recurrent collections (distal pancreatectomy or Roux-en-Y fistulojejunostomy), or uncontrolled sepsis; completion pancreatectomy rarely for grade C fistula after a Whipple
Flowchart of surgery for chronic pancreatitis
Diagram: choosing the operation in chronic pancreatitis

10. Complications

Chronic pancreatitis

  • Pseudocyst, duct stricture and stones
  • CBD stricture (obstructive jaundice), duodenal obstruction
  • Splenic vein thrombosis → sinistral portal hypertension, gastric varices
  • Pseudoaneurysm → bleeding into the duct (haemosuccus pancreaticus)
  • Pancreatic ascites, pleural effusion, fistulas
  • Exocrine insufficiency, diabetes, osteoporosis
  • Pancreatic cancer (risk 13 times higher; up to 40% in hereditary pancreatitis)
  • Opioid addiction, depression

Pseudocyst

  • Infection (abscess), rupture (ascites, peritonitis)
  • Bleeding (pseudoaneurysm into the cyst), obstruction (stomach, duodenum, CBD)

Treatment

  • Drainage → bleeding, perforation, stent migration, infection, recurrence
  • Resection → pancreatic fistula, delayed gastric emptying, diabetes, exocrine insufficiency

Mind map Pinch or scroll to zoom · drag to move

Show as a list

Chronic pancreatitis and cysts

  • Causes
    • Alcohol, smoking
    • Genetic: PRSS1
    • Autoimmune: IgG4
  • Features
    • Pain to back
    • Steatorrhoea
    • Diabetes
    • Calcification
  • Tests
    • Faecal elastase
    • CT, MRCP, EUS
    • Exclude cancer
  • Treatment
    • Stop alcohol, smoking
    • Creon
    • ERCP, ESWL
    • Puestow: dilated duct
    • Frey, Beger: head mass
    • Whipple if cancer
  • Pseudocyst
    • No epithelium
    • > 4 weeks
    • Watch if silent
    • Endoscopic cystgastrostomy
  • Cystic neoplasms
    • Serous: benign
    • MCN: women, resect
    • IPMN: main duct resect
    • SPN: young women
  • Fistula
    • Drain, nutrition
    • ERCP stent
    • Disconnected duct

More in State exam